Concepedia

Antibody responses to the <scp>SARS‐CoV</scp>‐2 vaccines in hemodialysis patients: Is inactivated vaccine effective?

Ahmet Murt, Mehmet Rıza Altıparmak, Serap Yadigar, Serkan Feyyaz Yalın, Doğukan Özbey, Bekir Kocazeybek, Meltem Pekpak, Muveddet Rezzan Ataman

Therapeutic Apheresis and Dialysis · 2021 · 18 citations · 12 references

DOIFull text

Open access

Abstract

When used in the same dose with the general population, inactivated SARS-CoV-2 vaccines generate reduced humoral response in hemodialysis patients. mRNA vaccines have better immunogenicity in this group.

References

12

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh, Robert W. Frenck, Ann R. Falsey et al. · New England Journal of Medicine · 2020 · 2.7K citations · Full text

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanrıöver, Levent Doğanay, Murat Akova et al. · The Lancet · 2021 · 922 citations · Full text

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu, Yaling Hu, Miao Xu et al. · The Lancet Infectious Diseases · 2021 · 572 citations · Full text

Presentation and Outcomes of Patients with ESKD and COVID-19

Anthony M. Valeri, Shelief Y. Robbins-Juarez, Jacob S. Stevens et al. · Journal of the American Society of Nephrology · 2020 · 367 citations · Full text

Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients

Héctor Rincón-Arévalo, Mira Choi, Ana‐Luisa Stefanski et al. · Science Immunology · 2021 · 282 citations · Full text